ACXP
Price
$4.08
Change
+$0.22 (+5.70%)
Updated
Sep 5 closing price
Capitalization
6.47M
73 days until earnings call
CRDF
Price
$2.17
Change
+$0.04 (+1.88%)
Updated
Sep 5 closing price
Capitalization
144.36M
54 days until earnings call
Interact to see
Advertisement

ACXP vs CRDF

Header iconACXP vs CRDF Comparison
Open Charts ACXP vs CRDFBanner chart's image
Acurx Pharmaceuticals
Price$4.08
Change+$0.22 (+5.70%)
Volume$29.96K
Capitalization6.47M
Cardiff Oncology
Price$2.17
Change+$0.04 (+1.88%)
Volume$1.29M
Capitalization144.36M
ACXP vs CRDF Comparison Chart in %
Loading...
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACXP vs. CRDF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and CRDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ACXP: $4.08 vs. CRDF: $2.17)
Brand notoriety: ACXP and CRDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 47% vs. CRDF: 63%
Market capitalization -- ACXP: $6.47M vs. CRDF: $144.36M
ACXP [@Biotechnology] is valued at $6.47M. CRDF’s [@Biotechnology] market capitalization is $144.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileCRDF’s FA Score has 0 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • CRDF’s FA Score: 0 green, 5 red.
According to our system of comparison, ACXP is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 5 TA indicator(s) are bullish while CRDF’s TA Score has 5 bullish TA indicator(s).

  • ACXP’s TA Score: 5 bullish, 3 bearish.
  • CRDF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than CRDF.

Price Growth

ACXP (@Biotechnology) experienced а -11.69% price change this week, while CRDF (@Biotechnology) price change was +3.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ACXP is expected to report earnings on Nov 18, 2025.

CRDF is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDF($144M) has a higher market cap than ACXP($6.47M). CRDF YTD gains are higher at: -50.000 vs. ACXP (-74.939). ACXP has higher annual earnings (EBITDA): -10.05M vs. CRDF (-53.95M). CRDF has more cash in the bank: 71M vs. ACXP (6.06M). ACXP has less debt than CRDF: ACXP (66.5K) vs CRDF (1.19M). CRDF has higher revenues than ACXP: CRDF (545K) vs ACXP (0).
ACXPCRDFACXP / CRDF
Capitalization6.47M144M4%
EBITDA-10.05M-53.95M19%
Gain YTD-74.939-50.000150%
P/E RatioN/AN/A-
Revenue0545K-
Total Cash6.06M71M9%
Total Debt66.5K1.19M6%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPCRDF
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIBH34.25N/A
N/A
CIB Marine Bancshares, Inc.
CSASF19.89N/A
N/A
Credit Saison Co., Ltd.
QQREF0.05N/A
N/A
Quebec Rare Earth Elements Corp.
ASBRF13.45-0.33
-2.39%
Asahi Group Holdings Ltd.
KSKGF1.98-0.14
-6.60%
Kingsgate Consolidated Ltd.

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and CERO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and CERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
+5.70%
CERO - ACXP
32%
Poorly correlated
-14.57%
HYPD - ACXP
32%
Poorly correlated
N/A
MGTX - ACXP
30%
Poorly correlated
-0.39%
ATAI - ACXP
29%
Poorly correlated
+0.22%
CRDF - ACXP
29%
Poorly correlated
+1.88%
More

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with QURE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
+1.88%
QURE - CRDF
42%
Loosely correlated
+1.24%
NAMS - CRDF
42%
Loosely correlated
+5.22%
MRVI - CRDF
41%
Loosely correlated
+6.36%
AKBLF - CRDF
37%
Loosely correlated
N/A
NRIX - CRDF
37%
Loosely correlated
+8.66%
More